ABA Chemicals Corporation (SHE:300261)
6.45
+0.01 (0.16%)
Apr 24, 2025, 2:45 PM CST
ABA Chemicals Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1,202 | 1,224 | 1,887 | 1,987 | 1,943 | Upgrade
|
Other Revenue | - | 54.83 | 114.15 | 84.81 | 60.42 | Upgrade
|
Revenue | 1,202 | 1,279 | 2,001 | 2,072 | 2,003 | Upgrade
|
Revenue Growth (YoY) | -6.00% | -36.09% | -3.42% | 3.42% | 20.36% | Upgrade
|
Cost of Revenue | 1,021 | 1,000 | 1,401 | 1,500 | 1,483 | Upgrade
|
Gross Profit | 181.58 | 278.48 | 599.68 | 571.9 | 520.37 | Upgrade
|
Selling, General & Admin | 188.09 | 193.6 | 192.45 | 201.45 | 156.16 | Upgrade
|
Research & Development | 123.28 | 117.65 | 130.37 | 123.23 | 117.47 | Upgrade
|
Other Operating Expenses | -1.67 | 11.68 | 13.37 | 12.58 | 13.7 | Upgrade
|
Operating Expenses | 309.7 | 345.86 | 349.26 | 338.95 | 287.95 | Upgrade
|
Operating Income | -128.11 | -67.39 | 250.42 | 232.94 | 232.42 | Upgrade
|
Interest Expense | - | -34.57 | -38.1 | -41.3 | -39.7 | Upgrade
|
Interest & Investment Income | 4.82 | 15.82 | 3.7 | 3.83 | 6.6 | Upgrade
|
Currency Exchange Gain (Loss) | - | 12.96 | 51.51 | -13.78 | -29.56 | Upgrade
|
Other Non Operating Income (Expenses) | -26.16 | -0.68 | -1.01 | -0.9 | -20.13 | Upgrade
|
EBT Excluding Unusual Items | -149.45 | -73.86 | 266.52 | 180.8 | 149.63 | Upgrade
|
Impairment of Goodwill | - | -42.52 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | -4.25 | 28.52 | -25.14 | 34.66 | 29.37 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.3 | 3.83 | 0.93 | -0.17 | 0.51 | Upgrade
|
Asset Writedown | -155.51 | -0.08 | -0.21 | -1.89 | -1.74 | Upgrade
|
Other Unusual Items | - | -4.7 | 2.41 | 5.25 | 8.4 | Upgrade
|
Pretax Income | -308.91 | -88.82 | 244.51 | 218.65 | 186.22 | Upgrade
|
Income Tax Expense | -44.78 | -16.46 | 24.97 | 23.13 | 13.65 | Upgrade
|
Earnings From Continuing Operations | -264.13 | -72.36 | 219.53 | 195.51 | 172.57 | Upgrade
|
Minority Interest in Earnings | 6.43 | -9.93 | -16.59 | -13.66 | -11.56 | Upgrade
|
Net Income | -257.7 | -82.29 | 202.95 | 181.85 | 161.01 | Upgrade
|
Net Income to Common | -257.7 | -82.29 | 202.95 | 181.85 | 161.01 | Upgrade
|
Net Income Growth | - | - | 11.60% | 12.94% | 97.22% | Upgrade
|
Shares Outstanding (Basic) | 955 | 955 | 955 | 955 | 957 | Upgrade
|
Shares Outstanding (Diluted) | 955 | 955 | 955 | 955 | 957 | Upgrade
|
Shares Change (YoY) | 0.01% | 0.01% | 0.00% | -0.28% | -0.57% | Upgrade
|
EPS (Basic) | -0.27 | -0.09 | 0.21 | 0.19 | 0.17 | Upgrade
|
EPS (Diluted) | -0.27 | -0.09 | 0.21 | 0.19 | 0.17 | Upgrade
|
EPS Growth | - | - | 11.60% | 13.26% | 98.35% | Upgrade
|
Free Cash Flow | 57.54 | -258.13 | -108.89 | 331.48 | 244.24 | Upgrade
|
Free Cash Flow Per Share | 0.06 | -0.27 | -0.11 | 0.35 | 0.26 | Upgrade
|
Dividend Per Share | - | - | 0.050 | - | 0.090 | Upgrade
|
Dividend Growth | - | - | - | - | 50.00% | Upgrade
|
Gross Margin | 15.10% | 21.77% | 29.97% | 27.61% | 25.97% | Upgrade
|
Operating Margin | -10.66% | -5.27% | 12.52% | 11.24% | 11.60% | Upgrade
|
Profit Margin | -21.44% | -6.44% | 10.14% | 8.78% | 8.04% | Upgrade
|
Free Cash Flow Margin | 4.79% | -20.18% | -5.44% | 16.00% | 12.19% | Upgrade
|
EBITDA | 5.41 | 66.01 | 382.02 | 359.14 | 356.92 | Upgrade
|
EBITDA Margin | 0.45% | 5.16% | 19.09% | 17.34% | 17.82% | Upgrade
|
D&A For EBITDA | 133.52 | 133.39 | 131.6 | 126.2 | 124.5 | Upgrade
|
EBIT | -128.11 | -67.39 | 250.42 | 232.94 | 232.42 | Upgrade
|
EBIT Margin | -10.66% | -5.27% | 12.52% | 11.24% | 11.60% | Upgrade
|
Effective Tax Rate | - | - | 10.21% | 10.58% | 7.33% | Upgrade
|
Revenue as Reported | - | 1,279 | 2,001 | 2,072 | 2,003 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.